Galecto logo
Galecto GLTO
report update icon

Quarterly report 2026-Q2
added 08-10-2026

Galecto Net Debt | GLTO

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Galecto

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-258 M -14.1 M -21.2 M -32 M -61.7 M -163 M -11 M -31 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-11 M -258 M -73.9 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Biotechnology industry

Issuer Net Debt Price % 24h Market Cap Country
Celsion Corporation Celsion Corporation
CLSN
-7.77 M - -6.63 % $ 13.9 M usaUSA
FSD Pharma FSD Pharma
HUGE
-16.8 M - 5743.5 % $ 69.7 M canadaCanada
Synthetic Biologics Synthetic Biologics
SYN
-10.8 M - 1.32 % $ 16.2 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-65.3 M - - $ 2.02 B usaUSA
I-Mab I-Mab
IMAB
-2.1 B - - $ 866 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
71 K - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
-402 M - - $ 40.3 B usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
-9.5 M - -6.08 % $ 184 M chinaChina
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-10.1 M - 1.35 % $ 17.8 M chinaChina
Genfit SA Genfit SA
GNFT
2.27 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-4.01 M - -13.47 % $ 169 M franceFrance
CureVac N.V. CureVac N.V.
CVAC
-443 M - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-824 K - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
-68.5 M - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
52 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
15.3 M - - $ 4.9 B britainBritain
Завод ДИОД Завод ДИОД
DIOD
-48.6 M - - - russiaRussia
Galera Therapeutics Galera Therapeutics
GRTX
-17 M - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-6.17 M - -18.52 % $ 27.3 M britainBritain
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
-14.6 M - -18.79 % $ 39.3 K usaUSA
ARCA biopharma ARCA biopharma
ABIO
-45 M - 1052.0 % $ 415 M usaUSA
MorphoSys AG MorphoSys AG
MOR
-146 M - 2.43 % $ 254 M germanyGermany
Codexis Codexis
CDXS
-7.74 M $ 1.46 2.82 % $ 127 M usaUSA
Ardelyx Ardelyx
ARDX
136 M $ 3.78 1.89 % $ 911 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
-31.3 M - -34.95 % $ 21.5 M germanyGermany
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
65.3 M $ 23.9 1.01 % $ 3.04 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
-55.8 M $ 36.6 1.3 % $ 410 M usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
5.43 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
-12.2 M - - $ 12.5 M belgiumBelgium
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
-3.85 M $ 7.12 6.91 % $ 4.76 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
17.3 M - - $ 344 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-340 M - - $ 3.67 B usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-3.5 M - -4.36 % $ 27 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
-1.39 B - - $ 3.37 B chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
-205 M $ 206.68 0.16 % $ 10.3 B usaUSA
GlycoMimetics GlycoMimetics
GLYC
-212 M - 9357.83 % $ 1.01 B usaUSA
AnaptysBio AnaptysBio
ANAB
-224 M $ 56.8 0.94 % $ 1.63 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-5.16 M - 5.93 % $ 314 M canadaCanada
AVROBIO AVROBIO
AVRO
-253 M - 1083.1 % $ 745 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
-1.3 B $ 66.53 0.15 % $ 12.8 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
-3.56 B - 0.49 % $ 251 B cayman-islandsCayman-islands
AIkido Pharma AIkido Pharma
AIKI
-31.2 M - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-30.2 M - - $ 1.01 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-5.53 M - -45.71 % $ 1.2 M canadaCanada
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
-625 M $ 4.3 1.42 % $ 298 M britainBritain
AlloVir AlloVir
ALVR
-96.6 M - 4.14 % $ 49.1 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
-62 M - -0.88 % $ 598 M usaUSA